Neurodevelopment in early treated HIV-infected infants participating in a developmental stimulation programme compared with controls.
Renate StrehlauMegan BurkeTamryn van AswegenLouise KuhnJoanne PottertonPublished in: Child: care, health and development (2020)
Early treated HIV-infected children participating in a neurodevelopmental stimulation programme achieved higher BSID-III scores at 12 months compared with early treated HIV-infected children who did not receive the programme.